vortioxetine (Brintellix) -

vortioxetine (Brintellix)
Information type: Drug best practice guidance
Source: Scottish Medicines Consortium
Specialities: Mental health and illness
Summary
Vortioxetine is accepted for restricted use within NHS Scotland for the treatment of major depressive episodes in adults. Use is restricted to patients who have experienced an inadequate response or been intolerant to two or more previous antidepressants.
UKMi comment
NICE TA367 recommends vortioxetine as an option for treating major depressive episodes in adults whose condition has responded inadequately to 2 antidepressants within the current episode.
Related links: NCIE TA367